72.19.Z - Other research and experimental development on natural sciences and engineering
26.40.Z - Manufacture of consumer electronics
27.90.Z - Manufacture of other electrical equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
62.09.Z - Other information technology and computer service activities
72.11.Z - Research and experimental development on biotechnology
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,5 | -0,4 | -0 | 91,6 |
EBITDA | -0,1 | -0 | 0 | 1614,7 |
Short time liabilities | 0 | 0 | 0 | 14,4 |
Equity capital | 0,8 | 0,4 | 0,4 | -7,4 |
Operating profit (EBIT) | -0,5 | -0,4 | -0 | 91,6 |
Assets | 0,8 | 0,4 | 0,4 | -7,2 |
Net profit (loss) | -0,5 | -0,4 | -0 | 91,6 |
Cash | 0 | 0 | 0 | 570,9 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 14,4 |
Net income from sale | 0,8 | 0,1 | 0 | -74,1 |
Working assets | 0,1 | 0 | 0,1 | 56,3 |
Depreciation | 0,4 | 0,4 | 0,1 | -86 |
% | % | % | p.p. | |
Profitability of capital | -60,8 | -89,1 | -8 | 81,1 |
Equity capital to total assets | 97,9 | 98,9 | 98,6 | -0,3 |
Gross profit margin | -62,5 | -294,5 | -95 | 199,5 |
EBITDA Margin | -7,1 | -1,1 | 64 | 65,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 8 | 13 | 59 | 46 |
Current financial liquidity indicator | 3.027859926223755 | 8.279308319091797 | 11.316158294677734 | 3 |
Net dept to EBITDA | 0.6521919369697571 | 3.379258871078491 | -1.4966981410980225 | -4,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane